J&J looking into booster of its single-dose vaccine
Johnson & Johnson said Wednesday it is "engaging" with the Food and Drug Administration, the Centers for Disease Control and Prevention and other health authorities on a booster of its single-dose COVID-19 vaccine.
The company said it "will share new data shortly regarding boosting" with its vaccine, which one study suggests provides immunity for at least eight months.
The statement comes after the Biden administration said Wednesday it is preparing to roll out booster shots of Pfizer's and Moderna's vaccines to more Americans next month.